Key facts
- Jack Fertility’s last known valuation is $5.1M (Jun 2025).
- It has raised $690K; the latest was Early Stage VC ($680K) in Jun 2025.
- Notable investors include Innovate UK, Fuel Ventures, Founders Factory, RoundX, Alma Angels — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Jack Fertility
- ·The full record, as it builds
Funding rounds
No funding rounds for Jack Fertility are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jack Fertility
Manufacturer of a male fertility sperm test kit intended to remove barriers to male reproductive healthcare. The company's kit offers lab-grade semen analysis, including motility, morphology, count, concentration, and volume, and offers convenient, discreet home collection with pre-paid return via postboxes, enabling individuals concerned about fertility to obtain personalised health insights and recommendations to guide their reproductive decisions.
- Sector
- Healthcare
- HQ
- Ashtead, United Kingdom
- Founded
- 2022
- Employees
- 5
- Website
- jackfertility.co.uk/
- Ownership
- Privately Held (backing)
Jack Fertility doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jack Fertility shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jack Fertility in its N-PORT filings yet. We sweep new filings monthly.